Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide.
about
Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistanceRegulation of the proteasome by ATP: implications for ischemic myocardial injury and donor heart preservationThe ubiquitin-proteasome system and cardiovascular diseaseN-acetylcysteine reduces oxidative stress, nuclear factor‑κB activity and cardiomyocyte apoptosis in heart failureRole of proteasomes in disease.Proteasome inhibitors and cardiac cell growthNF-kappaB-dependent induction of cathelicidin-related antimicrobial peptide in murine mast cells by lipopolysaccharideA nuclear import inhibitory peptide ameliorates the severity of cholecystokinin-induced acute pancreatitis.Hydrogen-rich saline attenuates acute renal injury in sodium taurocholate-induced severe acute pancreatitis by inhibiting ROS and NF-κB pathway.Activated microglia/macrophage whey acidic protein (AMWAP) inhibits NFκB signaling and induces a neuroprotective phenotype in microglia.Potential role of recombinant adeno-associated virus human thioredoxin-PR39 in cell and vascular protection against hypoxiaProteasome inhibitor (MG-132) treatment of mdx mice rescues the expression and membrane localization of dystrophin and dystrophin-associated proteinsTherapeutic proteasome inhibition in experimental acute pancreatitisEnhancement of 26S proteasome functionality connects oxidative stress and vascular endothelial inflammatory response in diabetes mellitus.Highbrow proteasome in high-throughput technology.Structure-function analyses involving palindromic analogs of tritrypticin suggest autonomy of anti-endotoxin and antibacterial activities.Atypical protein kinase C regulates dual pathways for degradation of the oncogenic coactivator SRC-3/AIB1.Plasticity in structure and interactions is critical for the action of indolicidin, an antibacterial peptide of innate immune origin.Noncompetitive modulation of the proteasome by imidazoline scaffolds overcomes bortezomib resistance and delays MM tumor growth in vivo.Role of peroxynitrite in the redox regulation of cell signal transduction pathwaysProtection of peroxiredoxin II on oxidative stress-induced cardiomyocyte death and apoptosis.Build it up-Tear it down: protein quality control in the cardiac sarcomere.Proteasome regulators: activators and inhibitors.Appetite for destruction: E3 ubiquitin-ligase protection in cardiac disease.Proteasome inhibition during myocardial infarction.Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity.Nuclear factor-kappa B inhibitors; a patent review (2006-2010).Proteasome inhibitors: possible novel therapeutic strategy for ischemia-reperfusion injury?Harnessing proteasome dynamics and allostery in drug design.The future of proteasome inhibitors in relapsed/refractory multiple myeloma.Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding.Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides.Dissecting a role of a charge and conformation of Tat2 peptide in allosteric regulation of 20S proteasome.Molecular mechanisms of acquired proteasome inhibitor resistance.Cytoplasmic trafficking of minute virus of mice: low-pH requirement, routing to late endosomes, and proteasome interaction.A mechanistic insight into a proteasome-independent constitutive inhibitor kappaBalpha (IkappaBalpha) degradation and nuclear factor kappaB (NF-kappaB) activation pathway in WEHI-231 B-cells.PI3-kinase p85alpha is a target molecule of proline-rich antimicrobial peptide to suppress proliferation of ras-transformed cells.Potential allosteric modulators of the proteasome activity.Mechanistic and functional studies of the interaction of a proline-rich antimicrobial peptide with mammalian cells.Activation of nuclear factor kappaB in acinar cells does not provoke acute pancreatitis
P2860
Q26991811-66DC27A8-A070-4DB7-9E4C-0E57B9BF7788Q27000202-1D1BE468-9E96-4303-94D1-B66C0966877DQ27021582-1F2A3791-BDB4-4AA9-AD30-ED40C7637B47Q28389987-EDCC1AD9-E4D7-49D9-BDE5-BC4723267AB8Q33307877-E68230A8-F86B-40A1-91AD-D5170D20565DQ33554490-46BB09BE-E1DD-4C58-B57A-1D46E1AFED6AQ33621811-8C9B738A-3DF5-4EDC-879B-B5A4B4013E24Q34605673-5A409B4A-D985-47BC-8C3E-D0B4055FB39EQ35283505-F652AC0D-2E65-486D-A775-B4AC9D0BE352Q35562493-F0F5D0E0-9BB8-41B5-BB03-EB665C62E7B2Q35754188-36966F8A-A703-4143-B210-2EFC3080F31FQ35792179-4371FE06-F93E-4349-A0E6-223F31534DF5Q36179048-40138A3D-0F11-4406-90D8-2D93C0133627Q36204680-9592ABDB-C7F3-4ECC-A812-CA4C48A5E31BQ36381253-B84D54B7-F4BB-401F-84D2-1EBCF9B4D72CQ36470440-60944C6F-91E3-4BF9-9F3E-DA1079965293Q36540639-ABF399E8-5C24-4B19-8441-A6BAAEEE7F25Q36639362-1E07F93D-9AB1-4104-A2DE-757EBCD34867Q36691554-5775CB1E-B111-4162-8FA2-916E79885C9EQ37159262-9C1DFF73-8D82-4E00-BF03-CC7071ED6B1DQ37219497-F78D75E1-103C-475E-879B-EBE67CBA9944Q37313697-30CE0723-1B4D-4A3A-94BB-48D40158EB80Q37411350-DCCA903E-EFFF-41A0-BE8F-09A8291249C6Q37526448-B3BAFC6B-45F7-43F0-83AD-AD0E545D4EC8Q37595119-0ED8072E-8C7E-4CF4-A3FD-3460F972E6B3Q37731798-3DB78523-9BE2-4792-9492-250A9374251FQ37958061-4C3EF7F8-382F-44ED-9D0C-3C44185A4E96Q38152513-0E5740E2-16B3-4EE0-814D-8275235E3B3CQ38177328-664A2490-FE60-4159-939D-64EA01011258Q38246060-A57A2705-1F4E-4959-844C-A8C81A794281Q38317744-0912A3CD-FBCC-4CC7-A1D4-495DDB78A83AQ39008879-38F7D678-75C8-47D1-AF49-57B133F11962Q39194017-188AC0A2-9104-430A-BBCE-B1D25D5E04CDQ39278628-DAED0358-4D90-48A2-841D-C01B57C2CD67Q39685590-E25DD32A-7353-4FDA-A113-4F41270087F4Q40592420-E09D7B6A-BAB7-4D7E-A029-EF5605264093Q40778525-F51A22C9-A5BE-4260-8FC0-0DCAEA86DBCDQ40942447-2F078202-1BB3-4816-A6D6-93BB77193B85Q42808621-82DA984F-7CBA-4EAE-B9C7-25952086D6EEQ42843384-2ADCCA28-5D80-4D4E-8D1E-B42598CC74DD
P2860
Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Inhibition of ubiquitin-protea ...... curring antibacterial peptide.
@en
type
label
Inhibition of ubiquitin-protea ...... curring antibacterial peptide.
@en
prefLabel
Inhibition of ubiquitin-protea ...... curring antibacterial peptide.
@en
P2093
P2860
P356
P1476
Inhibition of ubiquitin-protea ...... curring antibacterial peptide.
@en
P2093
A J Hietaranta
A K Saluja
A L Goldberg
P2860
P304
P356
10.1172/JCI9826
P407
P577
2000-08-01T00:00:00Z